Illumina Investor
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Technology:
Neurological Disorders
Industry:
Biotechnology, Genetics, Health Care, Medical
Headquarters:
San Diego, California, United States
Founded Date:
1998-01-01
Employees Number:
5001-10000
Funding Status:
IPO
Investor Type:
Accelerator
Investment Stage:
Early Stage Venture, Late Stage Venture
Number Of Exits:
6
Acquisitions Number:
6
Investors Number:
9
Total Funding:
28000000
Estimated Revenue:
$500M to $1B
Last Funding Date:
2000
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership